(Q45176499)

10 December 2017

title

Effects of oxcarbazepine and phenytoin on the EEG and cognition in healthy volunteers (English)

1 reference

10 December 2017

1 reference

M C Salinsky

1

1 reference

10 December 2017

D C Spencer

series ordinal

2

1 reference

10 December 2017

B S Oken

series ordinal

3

1 reference

10 December 2017

D Storzbach

series ordinal

4

1 reference

10 December 2017

publication date

1 December 2004

1 reference

10 December 2017

1 reference

10 December 2017

volume

5

1 reference

10 December 2017

issue

6

1 reference

10 December 2017

page(s)

894-902

1 reference

Results of a nationwide Veterans Administration Cooperative Study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

The new antiepileptic drugs: a systematic review of their efficacy and tolerability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

Optimizing health outcomes in active epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

Concentration-effect relationships with carbamazepine and its epoxide on psychomotor and cognitive function in epileptic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

Comparative cognitive effects of carbamazepine and phenytoin in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

Assessment of CNS effects of antiepileptic drugs by using quantitative EEG measures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

Diphenylhydantoin Serum Levels, Toxicity, and Neuropsychological Performance in Patients with Epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

Neuropsychological effects of carbamazepine and phenytoin: a reanalysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

Oxcarbazepine: Double-blind, randomized, placebo-control, monotherapy trial for partial seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

Comparison of oxcarbazepine and carbamazepine: a double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

Oxcarbazepine: pharmacokinetic interactions and their clinical relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

A neuropsychological battery for epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

Evaluating storage, retention, and retrieval in disordered memory and learning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

Computerized and conventional neuropsychological assessment of HIV-1-infected homosexual men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

Assessment of drowsiness in epilepsy patients receiving chronic antiepileptic drug therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

Test-retest reliability in EEG frequency analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

Intraindividual analysis of antiepileptic drug effects on EEG background rhythms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

The physiological (EEG) nature of drowsiness and its relation to performance deficits in narcoleptics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

Empirical techniques for determining the reliability, magnitude, and pattern of neuropsychological change after epilepsy surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

Empirical methods for assessing meaningful neuropsychological change following epilepsy surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

Dilantin toxicity. A clinical and electroence-phalographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

Studies on the metabolism of phenytoin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

Motor speed is a contaminating factor in evaluating the "cognitive" effects of phenytoin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.07.011

10.1016/J.YEBEH.2004.07.011

7 January 2021

Identifiers

DOI

1 reference

10 December 2017

1 reference